BAM
Bruderman Asset Management’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-7,965
| Closed | -$354K | – | 103 |
|
|
2019
Q3 | $354K | Sell |
7,965
-666
| -8% | -$29.6K | 0.09% | 95 |
|
|
2019
Q2 | $345K | Sell |
8,631
-3,000
| -26% | -$120K | 0.08% | 88 |
|
|
2019
Q1 | $486K | Sell |
11,631
-794
| -6% | -$33.2K | 0.11% | 95 |
|
|
2018
Q4 | $475K | Sell |
12,425
-2,754
| -18% | -$105K | 0.12% | 87 |
|
|
2018
Q3 | $610K | Sell |
15,179
-154,918
| -91% | -$6.23M | 0.14% | 85 |
|
|
2018
Q2 | $6.86M | Sell |
170,097
-89,896
| -35% | -$3.62M | 1.67% | 15 |
|
|
2018
Q1 | $10.2M | Buy |
259,993
+64,249
| +33% | +$2.51M | 2.43% | 13 |
|
|
2017
Q4 | $6.94M | Sell |
195,744
-121,959
| -38% | -$4.33M | 1.76% | 18 |
|
|
2017
Q3 | $12.9M | Buy |
317,703
+7,455
| +2% | +$303K | 3.34% | 8 |
|
|
2017
Q2 | $13.4M | Buy |
310,248
+73,014
| +31% | +$3.15M | 3.57% | 6 |
|
|
2017
Q1 | $10M | Buy |
237,234
+95,680
| +68% | +$4.03M | 2.89% | 12 |
|
|
2016
Q4 | $5.45M | Buy |
141,554
+9,635
| +7% | +$371K | 1.64% | 21 |
|
|
2016
Q3 | $5.69M | Buy |
131,919
+65,053
| +97% | +$2.81M | 1.7% | 19 |
|
|
2016
Q2 | $2.9M | Buy |
+66,866
| New | +$2.9M | 0.91% | 31 |
|
|
2015
Q3 | – | Sell |
-117
| Closed | -$5K | – | 434 |
|
|
2015
Q2 | $5K | Sell |
117
-1,133
| -91% | -$48.4K | ﹤0.01% | 390 |
|
|
2015
Q1 | $58K | Buy |
+1,250
| New | +$58K | 0.02% | 197 |
|